MoneyWorks4Me

Caplin Point Laboratories board to consider interim dividend

25 Jan 2016 Evaluate

Caplin Point Laboratories has informed that a meeting of the Board of Directors of the Company will be held on February 05, 2016, to consider, approve and take on record inter alia the Unaudited Financial Results for the quarter /Half year ended December 31, 2015, and to Consider and declare the payment of Interim dividend, if any for the Financial Year 2015-16. Accordingly, the Trading Window for dealing in the equity shares of the Company is closed for Promoters, Directors, other Connected Persons and Employees of the Company from December 21, 2015 to February 07,2016 as per the Company’s Code of Conduct to regulate, monitor and report trading by insiders adopted by the Board pursuant to SEBI(Prohibition of Insider Trading) Regulation,2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..